middle.news
Island Pharmaceuticals Presents Positive Phase 2a Dengue Trial Results
9:58am on Tuesday 16th of June, 2026 AEST
•
Healthcare
Read Story
Island Pharmaceuticals Presents Positive Phase 2a Dengue Trial Results
9:58am on Tuesday 16th of June, 2026 AEST
Key Points
ISLA-101 shows broad antiviral activity against dengue and related viruses
Phase 2a PROTECT study confirms safety and antiviral signals
Treatment cohort reveals promising antiviral activity
Plans underway for Phase 2b and Phase 3 clinical trials
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Island Pharmaceuticals (ASX:ILA)
OPEN ARTICLE